Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Fenwal and Golden Meditech Agree to Terms for Medical Device JV

publication date: Mar 9, 2011
Fenwal, a US headquartered company, and Golden Meditech Holdings of Hong Kong have arrived at definitive terms for their medical device JV. The JV will manufacture and market products and technologies for blood collection, storage and transfusion in China. Fenwal will own 51% of the venture, with the remaining 49% belonging to Golden Meditech. More details....

Stock Symbol: (HK: 801; TW: 910801)     Share this with colleagues:  


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital